Our Approach to Investing in Genomics and Biosciences
It’s hard to believe that it has been a year and a half since we updated our healthcare thesis, as a follow-up to our blog series with Union Square Ventures on the future of healthcare. While we are still spending time on digital health, we have been focusing more on genomics and biosciences as a means to […]
Personalized medicine can’t come soon enough
I’m scheduling my fourth knee surgery. But Ange… how is that possible when you only have 2 knees? Many years of playing Ultimate Frisbee… As I’m heading into this surgery, it has occurred to me that personalized medicine cannot come soon enough. Below I’m going to share my own health story and struggles associated with […]
Introducing our first investment in genomics, Gencove – making genomic data accessible and useful
Today, we’re excited to announce our first investment in the genomics space. We welcome Gencove to the Version One portfolio: they’re making genomics accessible and useful to all. We first met Joe Pickrell, the founder of Gencove, a year ago when he shared that he was building an inexpensive technology that actually sequences the genome […]
My next chapter of VC: More data!
On the heels of being named principal last week, I am humbled by Boris’s announcement and thrilled to begin leading deals for Version One. While many of you have already worked with me directly or read my thoughts on this blog over the years, I want to take the opportunity to share my goals: what I’m […]